Physician profile
Neil T Chen
NPI 1053324244
$4,174.86
in general payments reported to CMS, 2019-2025
7 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Surgery of The Hand (Plastic Surgery) provider received nationally (typical 2025 total: $312).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,195 · 2020: $150 · 2021: $44.00 · 2022: $140 · 2023: $81.54 · 2024: $458 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $435 · Long Term Medical Supply Or Device Loan: $211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $434.77 |
| Long Term Medical Supply Or Device Loan | $211.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $2,920.29 | 2019 | |
| Mentor Worldwide LLC | $441.60 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Pacira Pharmaceuticals Incorporated | $262.03 | 2019 | |
| Integra Lifesciences Corporation | $211.31 | 2024 | Durasorb Monofilament Mesh |
| Galderma Laboratories, L.P. | $150.00 | 2020 | |
| Kerecis Limited | $96.14 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Abbvie INC. | $93.49 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.